A Phase 1/2 Study in Subjects With Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma, Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ADH300004 (Eniluracil) With Escalating Doses of 5 Fluorouracil Administered Orally Once Weekly for 3 Weeks Out of Every 4 (Adherex Protocol Number AHX-03-103)
Phase of Trial: Phase I/II
Latest Information Update: 14 Dec 2008
At a glance
- Drugs Eniluracil; Fluorouracil
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Fennec Pharmaceuticals
- 14 Dec 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Nov 2006 New trial record.